Preclinical Evaluation of Safety, Pharmacokinetics, Efficacy, and Mechanism of Radioprotective Agent HL-003

Amifostine is a radioprotector with high efficacy but poor safety, short half-life, no oral formulation, and poor compliance, which limits its application. With the increasing risk of exposure to radiation, the development of new radioprotective agents is critical. We previously synthesized a new am...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yahong, Miao, Longfei, Guo, Yuying, Tian, Hongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914087/
https://www.ncbi.nlm.nih.gov/pubmed/33688393
http://dx.doi.org/10.1155/2021/6683836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914087/
https://www.ncbi.nlm.nih.gov/pubmed/33688393
http://dx.doi.org/10.1155/2021/6683836

Ejemplares similares